Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03829618 · ClinicalTrials.gov registry record · Phase 3
Lidocaine Administration During Flexible Bronchoscopy and Endobronchial Ultrasound
A Phase 3 study, sponsored by Milton S. Hershey Medical Center.
- Terminated
- Registry status
- Phase 3
- Development phase
- 29
- Enrollment target
NCT03829618: Clinical Trial Phase 3 study, sponsored by Milton S. Hershey Medical Center.
NCT03829618 is a Phase 3 study that was terminated before completion, run by Milton S. Hershey Medical Center. The registered enrollment target is 29 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03829618, a Phase 3 study, was terminated before completion, sponsored by Milton S. Hershey Medical Center.
- TERMINATED
- Registry status
- Phase 3
- Development phase
- 29 participants
- Enrollment target
Study Summary
The purpose of this study is to assess if there is decrease in cough during flexible bronchoscopy and endobronchial ultrasound when different modes of lidocaine administration are used. The modes of administration being evaluated are topical, nebulized and atomized.
Primary Outcome
Number of coughs during procedure as defined by cough requiring stopping procedure or treatment by anesthesiologist with propofol or alfentanyl
Interventions
- DRUG Topical lidocaine
- DRUG Nebuliser solution
- DRUG Nebuliser Suspension
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 29 participants |
| Start Date | 2019-04-01 |
| Est. Completion | 2020-08-31 |
| Phase | Phase 3 |
Why NCT03829618 stopped before completion
NCT03829618 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 29 participants, a relatively small participant target, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 3 interventions - of which Topical lidocaine is the first listed.
NCT03829618 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03829618 about?
NCT03829618 is a clinical study titled "Lidocaine Administration During Flexible Bronchoscopy and Endobronchial Ultrasound". The purpose of this study is to assess if there is decrease in cough during flexible bronchoscopy and endobronchial ultrasound when different modes of lidocaine administration are used. The modes of administration being evaluated are topical, nebulized and atomized.
What is the current status of trial NCT03829618?
This trial is currently terminated. It is a Phase 3 study. The enrollment target is 29 participants. The study started on 2019-04-01. Estimated completion is 2020-08-31.
What interventions are being tested in trial NCT03829618?
The interventions under investigation include: Topical lidocaine (DRUG), Nebuliser solution (DRUG), Nebuliser Suspension (DRUG).
Who is sponsoring clinical trial NCT03829618?
This trial is sponsored by Milton S. Hershey Medical Center, which has 396 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03829618's enrollment target sits among peer trials
29 1933rd of 2000 higher than 66 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02429557 · 29 participants · Phase 1
Hemodynamic Mechanisms of Abdominal Compression in the Treatment of Orthostatic Hypotension in Autonomic Failure
- NCT02568878 · 29 participants · Phase 3
Creatine for Depressed Male and Female Methamphetamine Users
- NCT03014401 · 29 participants · NA
The Effect of Adipose-Derived Stem Cells for Knee Osteoarthritis
- NCT03128996 · 29 participants · Phase 1
Reduced Intensity Conditioning and Familial HLA-Mismatched BMT for Non-Malignant Disorders
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI